Vol 9, No 3 (2015)

Objective: to study the levels of PA and its relationship with other risk factors among the working population of the Ryazan Region.
Material and methods. The MERIDIAN­RO study was conducted as a prospective cohort with cross­sectional and retrospective study in­ cluded a sample of biochemical, ECG and a survey using a standardized questionnaire. The level of physical activity was assessed by ques­ tionnaire CINDI and then was revised by questionnaire IPAQ. In a study from 2011 it included 1,622 people (in 1220 – a city, 402 – village) aged 25–64 years (mean age – 43,4 ± 11,4 years), of which 42.6 % were male, 53.8 % – female.
Results. The level of low PA in the Ryazan Region, measured by questionnaire IPAQ was 22.9 % (24.3 % in urban and 18.4 % in rural areas, p = 0.014). With multinomial logistic regression were established association between the PA and the low presence of higher education (OR 3.63; 95 % CI 2,26–5,85, p = 0.0001, Wald 28.172), smoking (OR 1.32, 95 % CI 1,01–1,72, p = 0.045, Wald 4,031) and elevated levels of Lp (a) more than 30 mg/dl (OR 1.38, 95 % CI 1,04–1,83, p = 0.024, Wald 5.119). It was also revealed a high demand for advice on improving the PA (74.5 %). Conclusion. The low level of PA in the Ryazan Region, as measured by the IPAQ questionnaire was 22.9 % (24.3 % in urban and 18.4 % in rural areas, p = 0.014), which is lower than Russian average. High demand for advice on improving the FA and created conditions for in­ creasing its level in the region indicate the need to intensify work among the population in this area. 

Objective: to estimate the quality of antiaggregants therapy in patients with coronary heart disease in outpatient settings.
Materials and methods. The data of the retrospective outpatient RECVAD registry (3690 patients who lived in Ryazan and its Region and had evidence in their outpatient medical records for one of the diagnoses, such as coronary heart disease, hypertension, chronic heart failure, atrial fibrillation, or their concurrence, were used. Forty­nine patients after acute myocardial infarction (AMI) and/or percutaneous coro­ nary interventions (PCI) with stenting ≤ 1 year before their inclusion in the registry, who were to undergo dual antiaggregant therapy (DAT) according to current clinical guidelines (CG), were identified among 427 patients after AMI and/or PCI with coronary angioplasty. Contra­ indications to DAT were simultaneously revealed and a relationship of the use of therapy to their presence was compared.
Results. Among the 49 patients who had indications for DAT that was used in 15 (30.6 %) cases and that was not in 3 (6.1 %) patients in the presence of contraindications, 25 (51.0 %) did not receive DAT in the absence of contraindications and 6 (12.3 %) patients received the therapy in the presence of contraindications.
Conclusion. DAT prescribed by outpatient physicians does not always meet the current CG. There are cases of not using DAT in the presence of obvious indications for DAT and, on the contrary, those of its use in the presence of contraindications.